Efficacy and Safety of Lesinurad (RDEA594), A Novel Uricosuric Agent, Given In Combination with Allopurinol in Allopurinol-Refractory Gout Patients: Preliminary Results from the Randomized, Double-Blind, Placebo-Controlled, Phase 2B Extension Study.

  1. Sundy, John
  2. Perez-Ruiz, Fernando
  3. Krishnan, Eswar
  4. Hingorani, Vijay
  5. Welp, Jody
  6. Suster, Matt
  7. Manhard, Kimberly
  8. Cravets, Matt
  9. Hagerty, David
  10. Quart, Barry
Revista:
ARTHRITIS AND RHEUMATISM

ISSN: 0004-3591 1529-0131

Año de publicación: 2011

Volumen: 63

Número: 10

Congreso: 75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP)

Tipo: Aportación congreso